+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Biological Characterization of the Anti-Tumor Properties of Novel Dual-Target Inhibitors of Dihydrofolate Reductase and Thioredoxin Reductase



Biological Characterization of the Anti-Tumor Properties of Novel Dual-Target Inhibitors of Dihydrofolate Reductase and Thioredoxin Reductase



Free Radical Biology and Medicine 100: S119-S120




(PDF emailed within 0-6 h: $19.90)

Accession: 064816183

Download citation: RISBibTeXText

DOI: 10.1016/j.freeradbiomed.2016.10.308


Related references

Design, Synthesis, and Biological Evaluation of Coupled Bioactive Scaffolds as Potential Anticancer Agents for Dual Targeting of Dihydrofolate Reductase and Thioredoxin Reductase. Journal of Medicinal Chemistry 60(5): 1734-1745, 2017

Anti-MRSA dihydrofolate reductase inhibitors Biological characterization. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 336, 1999

Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity. European Journal of Medicinal Chemistry 115: 63-74, 2016

The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase. Biochimica et Biophysica Acta 1054(1): 14-20, 1990

CoMFA and CoMSIA analyses of Pneumocystis carinii dihydrofolate reductase, Toxoplasma gondii dihydrofolate reductase, and rat liver dihydrofolate reductase. Journal of Medicinal Chemistry 48(5): 1448-1469, 2005

Anti-Pneumocystis carinii and anti-tumor activity of certain pteridine-based metabolically inert inhibitors of dihydrofolate reductase. Proceedings of the American Association for Cancer Research Annual Meeting 42: 293, March, 2001

Lead discovery of inhibitors of the dihydrofolate reductase domain of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase. Biochemical and Biophysical Research Communications 235(3): 515-519, 1997

Changes in the activities of dihydrofolate reductase and thioredoxin reductase in sea urchin eggs following fertilization. Cell Differentiation, 115-6: 297-298, 1982

Plasmodium dihydrofolate reductase-thymidylate synthase as anti-malarial target Structure and implications for development of new effective inhibitors. Experimental Parasitology 105(1): 16, 2003

The dihydrofolate reductase domain of Plasmodium falciparum thymidylate synthase-dihydrofolate reductase. Gene synthesis, expression, and anti-folate-resistant mutants. Journal of Biological Chemistry 268(29): 21637-21644, 1993

Design, synthesis, and biological activity of classical N- pyrimidine-5-YLethylbenzoyl-L-glutamic acids as dual inhibitors of dihydrofolate reductase and thymidylate synthase. Abstracts of Papers American Chemical Society 221(1-2): MEDI 161, 2001

Structural studies on bioactive compounds 8. synthesis crystal structure and biological properties of a new series of 2 4 diamino 5 aryl 6 ethylpyrimidine dihydrofolate reductase inhibitors with in vivo activity against a methotrexate resistant tumor cell line. Journal of Medicinal Chemistry 32(11): 2468-2474, 1989

Synthesis, crystal structure and biological properties of a new series of lipophilic s-triazines, dihydrofolate reductase inhibitors. European Journal of Medicinal Chemistry 28(2): 149-158, 1993

Design, synthesis, and biological evaluation of classical and nonclassical 2-amino-4-oxo-5-substituted-6-methylpyrrolo[3,2-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors. Journal of Medicinal Chemistry 51(1): 68-76, 2007

Design, synthesis, and biological evaluation of classical and nonclassical 2-amino-4-oxo-5-substituted-6-methylpyrrolo3,2-dpyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors. 2008